Together with existing data on the prevalent expression of GSTP1 in cancer cells, our study findings are in line with previous vitro experiment, indicating that the human 105 Val variant of the GSTP1 enzyme was significantly more active against cisplatin than the enzyme containing the IIe residue.14,15 Our results are in line with previous clinical studies. This evidence concerns the gene GSTP1 and cancer.